참고문헌
- Alberti KG, Eckel RH, Grundy SM, et al (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
- Beebe Dimmer JL, Dunn RL, Sarma AV, et al (2007). Features of the metabolic syndrome and prostate cancer in African- American men. Cancer, 109, 875-81. https://doi.org/10.1002/cncr.22461
- Beebe Dimmer JL, Nock NL, Neslund-Dudas C, et al (2009). Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology, 74, 185-90. https://doi.org/10.1016/j.urology.2009.03.013
- Buschemeyer WC III, Freedland SJ (2007). Obesity and prostate cancer: Epidemiology and clinical implications. Eur Urol, 52, 331-43. https://doi.org/10.1016/j.eururo.2007.04.069
- Chan JM, Stampfer MJ, Giovannucci E, et al (1998). Plasma insulin-like growth factor-I and pros- tate cancer risk: a prospective study. Science, 279, 563-6. https://doi.org/10.1126/science.279.5350.563
- De Nunzio C, Freeland S, Miano R, et al (2011). Meatabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy. Prostate, 71, 1492-8.
- Epstein JI, Allsbrook WC Jr, Amin MB, et al (2005). The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol, 29, 1228-42. https://doi.org/10.1097/01.pas.0000173646.99337.b1
- Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013). Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8. https://doi.org/10.7314/APJCP.2013.14.1.243
- Hammarsten J, Hogstedt B (2004). Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press, 13, 47-55. https://doi.org/10.1080/08037050310025735
- Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr, 86, 843-57. https://doi.org/10.1093/ajcn/86.3.843S
- Jeon KP, Jeong TY, Lee SY, et al (2012). Prostate cancer in patients with metabolic syndrome is associated with low grade gleason score when diagnosed on biopsy. Korean J Urol, 53, 593-7. https://doi.org/10.4111/kju.2012.53.9.593
- Kang DI, Chung JI, Ha HK, et al (2013). Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev, 14, 6913-7. https://doi.org/10.7314/APJCP.2013.14.11.6913
- Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000). The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev, 21, 215-44. https://doi.org/10.1210/edrv.21.3.0399
- Kim YJ, Cho YJ, Oh JE, et al (2008). The association between metabolic syndrome and prostate-specific antigen levels. Int J Urol, 15, 905-9. https://doi.org/10.1111/j.1442-2042.2008.02137.x
- Kristal AR, Chi C, Tangen CM, et al (2006). Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer, 106, 320-8. https://doi.org/10.1002/cncr.21603
- Laukkanen JA, Laaksonen DE, Niskanen L, et al (2004). Metabolic syndrome and the risk of prostate cancer in Finnish men: a population based study. Cancer Epidemiol Biomarkers Prev, 13, 1646-50.
- LeRoith D, Roberts CT Jr (2003). The insulin-like growth factor system and cancer. Cancer Lett, 195, 127-37. https://doi.org/10.1016/S0304-3835(03)00159-9
- Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev, 13, 4097-100. https://doi.org/10.7314/APJCP.2012.13.8.4097
- Martin RM, Vatten L, Gunnell D, et al (2009). Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer Causes Control, 20, 1181-92. https://doi.org/10.1007/s10552-009-9319-x
- Oliver SE, Gunnell D, Donovan J, et al (2004). Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer, 108, 887-92. https://doi.org/10.1002/ijc.11631
- Ozbek E, Otunctemur A, Dursun M, et al (2014) Association between the Metabolic Syndrome and High Tumor Grade and Stage of Primary Urothelial Cell Carcinoma of the Bladder. Asian Pac J Cancer Prev, 15, 1447-51. https://doi.org/10.7314/APJCP.2014.15.3.1447
- Ozbek E, Otunctemur A, Sahin S, et al (2013). Renal cell carcinoma is more aggressive in Turkish patients with the metabolic syndrome. Asian Pac J Cancer Prev, 14, 7351-4. https://doi.org/10.7314/APJCP.2013.14.12.7351
- Pandeya DR, Mittal A, Sathian B, Bhatta B (2014). Role of hyperinsulinemia in increased risk of prostate cancer: a case control study from Kathmandu Valley. Asian Pac J Cancer Prev, 15, 1031-3. https://doi.org/10.7314/APJCP.2014.15.2.1031
- Parekh N, Lin Y, Marcella S, et al (2008). Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004). Cancer Epidemiol Biomarkers Prev, 17, 2467-72. https://doi.org/10.1158/1055-9965.EPI-08-0059
- Pelucchi C, Negri E, Talamini R, et al (2010). Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer, 46, 1866-72. https://doi.org/10.1016/j.ejca.2010.03.010
- Platz EA, Leitzmann MF, Rifai N, et al (2005). Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev, 14, 1262-9. https://doi.org/10.1158/1055-9965.EPI-04-0371
- Pothiwala P, Jain SK, Yaturu S (2009). Metabolic syndrome and cancer. Metab Syndr Relat Disord, 7, 279-88. https://doi.org/10.1089/met.2008.0065
- Renehan AG, Zwahlen M, Minder C, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53. https://doi.org/10.1016/S0140-6736(04)16044-3
- Rosato V, Zucchetto A, Bosetti C, et al (2011). Metabolic syndrome and endometrial cancer risk. Ann Oncol, 22, 884-9. https://doi.org/10.1093/annonc/mdq464
- Rosato V, Tavani A, Bosetti C, et al (2011). Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis. Metabolism, 60, 1372-8. https://doi.org/10.1016/j.metabol.2011.03.005
- Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. https://doi.org/10.3322/caac.20121
- Teloken C, Da Ros CT, Caraver F, et al (2005). Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol, 174, 2178-80. https://doi.org/10.1097/01.ju.0000181818.51977.29
- Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem, 266, 37-56. https://doi.org/10.1023/B:MCBI.0000049134.69131.89
- Werny DM, Saraiya M, Gregg EW (2006). Prostate-specific antigen values in diabetic and non-diabetic US men, 2001- 2002. Am J Epidemiol, 164, 978-83. https://doi.org/10.1093/aje/kwj311
- Zhou JR, Blackburn GL, Walker WA (2007). Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr, 86, 817-9. https://doi.org/10.1093/ajcn/86.3.817S
피인용 문헌
- Association of Polymorphisms in Stress-Related TNFα and NPY Genes with the Metabolic Syndrome in Han and Hui Ethnic Groups vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5895
- Evaluation of Environmental Risk Factors for Prostate Cancer in a Population of Iranian Patients vol.15, pp.24, 2014, https://doi.org/10.7314/APJCP.2014.15.24.10603
- Human Kallikrein-2, Prostate Specific Antigen and Free-Prostate Specific Antigen in Combination to Discriminate Prostate Cancer from Benign Diseases in Syrian Patients vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7085
- Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort vol.18, pp.2, 2015, https://doi.org/10.1038/pcan.2015.12
- Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma vol.34, pp.3, 2015, https://doi.org/10.1186/s40880-015-0009-7
- Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2442-7
- Meta-analysis of metabolic syndrome and prostate cancer vol.20, pp.2, 2017, https://doi.org/10.1038/pcan.2017.1
- Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer vol.95, pp.40, 2016, https://doi.org/10.1097/MD.0000000000005085